QuickLinks
 -- Click here to rapidly navigate through this document
 








































 
 

  Exhibit 10.2    
    


[SYNTA
LETTERHEAD] 


July 8,
2008 


REVISED  


Michael Bailey

[ADDRESS] 


Dear
Michael: 


        On
behalf of Synta Pharmaceuticals, I am pleased to offer you the position of Sr. Vice President and Chief Commercial Officer reporting to Safi Bahcall, President and Chief Executive
Officer for Synta Pharmaceuticals Corp. (hereinafter "Synta Pharmaceuticals" or the "Company"). 


        1.    Effective Date:    The effective date of your employment will be August 4, 2008. 


        2.    Compensation:    Your initial base salary will be $300,000.00 annually; payable at a semi-monthly
rate of $12,500.00, from which all applicable taxes and other customary employment-related deductions will be taken. 


        For
the first annual performance review following your hire date, all pay-for-performance compensation (such as merit increases and bonuses) will be
pro-rated to reflect your start date and the percentage of the calendar year that you worked. Employees who start after October 31st will not be included in the
performance review for that calendar year. 


        3.    Bonus:    You will be eligible to receive an annual performance based bonus. This cash bonus, for fully meeting
and exceeding expectations under the Company's bonus program, is expected to be at a target level of 40% of your base salary. Such bonus, if any, will be granted at the discretion of the Company's
Board of Directors. 


        4.    Stock Option:    You will be granted an incentive stock option to purchase 150,000 shares of the Company's
common stock pursuant to the terms of the Synta Pharmaceuticals Corp. 2006 Stock Plan (the "Plan") and formal stock option agreement. All stock option grants shall be priced at the fair market value
(as defined in the 2006 plan) on the grant date and are subject to a vesting schedule over four years (25% vest on the first year anniversary of your hire date and the remainder in equal portions
quarterly over the next three years.) 


        You
will also be granted 25,000 restricted shares of Synta stock with the following vesting schedule: 50% vest on the second anniversary of your hire date and the remainder on the third
anniversary of your hire date. 


        5.    Severance and Change of Control:    Please refer to the document included with this offer of employment entitled
Severance and Change of Control Agreement which is attached hereto and incorporated herein by reference. 


        6.    Benefits:    As a full-time employee, you will be eligible to participate in certain Company-
sponsored benefit plans to the same extent as, and subject to the same terms, conditions and
limitations applicable to other employees of the Company of similar rank and tenure. All benefits may be changed or modified from time to time at the Company's sole discretion. 



        7.    Employment Period:    Your employment with the Company will be at-will, meaning that you will not be
obligated to remain employed by the Company for any specified period of time; likewise, the Company will not be obligated to continue your employment for any specific period and may terminate your
employment at any time, with or without cause. 


A-1







 

        8.    Contingencies:    Our employment offer to you is contingent upon (1) your execution of the standard form
of Non-Competition, Confidentiality and Inventions Agreement (a copy of which is attached hereto as Exhibit A); (2) your
ability, as required under federal law, to establish your employment eligibility as a U.S. citizen, a lawful permanent resident of the U.S. or an individual specifically authorized for employment by
the Immigration and Naturalization Service; and (3) completion of a satisfactory background check. If any of the foregoing conditions are not met, this employment offer shall be null and void. 



        9.    Jurisdiction and Waiver:    In the case of any dispute, this offer of employment shall be interpreted under the
laws of the Commonwealth of Massachusetts. By accepting this offer of employment, you agree that any action, demand, claim or counterclaim in connection with any aspect of your employment with the
Company, or any separation of employment (whether voluntary or involuntary) from the Company, shall be resolved in a court of competent jurisdiction in Massachusetts by a judge alone, and you
knowingly waive and forever renounce your right to a trial before a civil jury. 



        10.    Medical Surveillance:    As part of Synta's medical surveillance program, all laboratory employees working with
hazardous chemical, infectious agents, radio labeled materials or animals are required to have an initial physical provided by Mount Auburn Hospital. An employee may refuse an exam by signing a
release. If you want to decline from having the initial physical, please notify Human Resources on your first day at New Employee Orientation. Your initial surveillance examination will be scheduled
to take place during the first 10 days of your employment. 



        11.    Orientation:    On your first day of employment, please arrive at 45 Hartwell Avenue at 8:30am for benefits
enrollment with Human Resources. 


        Michael,
we are very enthusiastic about the prospect of your joining us as a Synta Pharmaceuticals employee. Please indicate your acceptance of the foregoing by signing one enclosed copy
of this letter
and returning it to Art McMahon within seven days of the date of this letter. After that date, this offer will lapse. If you need additional time to respond to this offer, please let us know
immediately. 





			
	Sincerely,	 	 
	
 SYNTA PHARMACEUTICALS CORP.	
 	

 
	
 /s/ SAFI BAHCALL






  Safi Bahcall, Ph.D.

Director, President and Chief Executive Officer	
 	

 






Agreed
to and accepted: 





					
	Name:	 	/s/ MICHAEL P. BAILEY







 	 	Date: 7/9/08





A-2








 




































 EXHIBIT A  


Synta Pharmaceuticals Corp.

45 Hartwell Avenue

Lexington, MA 02421 


June 13,
2008



Michael
Bailey

[ADDRESS] 


Dear
Michael: 


        This
letter is to confirm our understanding with respect to (i) your agreement not to compete with Synta Pharmaceuticals Corp. or its subsidiaries or affiliates (collectively, the
"Company") and (ii) your agreement to protect and preserve information and property which is confidential and proprietary to the Company (the terms and conditions agreed to in this letter shall
hereinafter be referred to as the "Agreement"). You hereby acknowledge and agree that you are an "at-will" employee and that no provision of this Agreement shall be construed to create an
express or implied employment
contract, or a promise of employment for a specific period of time, and the Company expressly reserves the right to end your employment at any time, with or without notice or cause. 


        In
consideration of your employment by the Company, the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby mutually acknowledged, we have agreed as follows: 


        1.    Prohibited Competition and Solicitation.    



        (a)    Certain Acknowledgments and Agreements.    



          (i)  We
have discussed, and you recognize and acknowledge the competitive and proprietary aspects of the business of the Company. 



         (ii)  You
will devote your full time and efforts to the business of the Company and, during the period of your employment with the Company (the "Term") and for a period of
twelve (12) months following termination of your employment (whether such termination is voluntary or involuntary. If such termination is involuntary and through no fault of your own, the
twelve (12) month non-compete restriction as discussed herein will not apply), shall not participate, directly or indirectly, in any capacity, in any business which is competitive
with the Company without the prior written consent of the Company. You acknowledge and agree that a business will be deemed competitive with the Company if it conducts research, performs any of the
services or manufactures or sells any of the products provided or offered by the Company or if it performs any other services and/or engages in the production, manufacture, distribution or sale of any
product that may be purchased in lieu of purchasing services performed or products produced, manufactured, distributed or sold by the Company within the Field of Interest (as defined below) at any
time during the period of your employment with the Company. 


        (iii)  You
further acknowledge and agree that, during the course of your employment with the Company, the Company will furnish, disclose or make available to you confidential
and proprietary information related to the Company's business and that the Company may provide you with unique and specialized training. You also acknowledge that such confidential information and
such training have been developed and will be developed by the Company through the expenditure by the Company of substantial time, effort and money and that all such confidential information and
training could be used by you to compete with the Company. 




A-3







 




        (b)    Non-Solicitation.    During the Term and for a period of twelve (12) months following
termination of your employment, whether such termination is voluntary or involuntary, you shall not, without the prior written consent of the Company: 



          (i)  either
individually or on behalf of or through any third party, solicit, divert or appropriate or attempt to solicit, divert or appropriate, any customer of the Company
with which you had any contact at any time during the Term, with the effect or intention of reducing or limiting the amount of business the customer does with the Company; or 



         (ii)  either
individually or on behalf of or through any third party, directly or indirectly, solicit, entice or persuade or attempt to solicit, entice or persuade any
employees of or consultants to the Company (other than your spouse), who have been employees or consultants of the Company at any time during the Term, or who are employees at the time of the
solicitation, to leave the services of the Company. 




        (c)    Field of Interest.    As used herein, the term "Field of Interest" means the research of, and/or the
development, manufacture and sale of, any therapeutic or diagnostic product that is developed, manufactured or sold by the Company at any time during the Term, as documented in the
bi-weekly scientific project reports or other scientific planning documents of the company (the "Scientific Reports") prepared by the Company during the Term. You hereby acknowledge and
agree that the Field of Interest shall be assessed for purposes of this Agreement as of the date on which your employment with the Company terminates, which assessment shall include, without
limitation, a review of the applicable Scientific Reports. 


        (d)    Reasonableness of Restrictions.    You further acknowledge and agree that (i) the activities which are
prohibited by this Section 1 are narrow and reasonable in relation to the skills which represent your principal salable asset both to the Company and to your other prospective employers, and
(ii) given the global nature of the Company's business, including its need to market its services and sell its products in a large geographic area in order to have a sufficient customer base to
make the Company's business profitable, the geographic, length of time and substantive scope of the provisions of this Section 1 are reasonable, legitimate and fair to you. 


        (e)    Survival of Acknowledgments and Agreements.    Except as expressly set forth hereunder, your acknowledgments
and agreements set forth in this Section 1 shall survive the termination of your employment with the Company for the periods set forth above. 




        2.    Protected Information.    



        (a)    Confidentiality Obligations.    You shall at all times, both during the Term and thereafter, maintain in
confidence and shall not, without the prior written consent of the Company, use, except in the course of performance of your duties for the Company, disclose or give to others any Confidential
Information of the Company. As used herein, the term "Confidential Information" shall mean any information which is disclosed to or developed by you during the course of performing services for, or
receiving training from, the Company, and is not generally available to the public, including but not limited to confidential information concerning business plans, customers, future customers,
suppliers, licensors, licensees, partners, investors, affiliates or others, training methods and materials, financial information, sales prospects, client lists, Company Inventions (as defined in
Section 3), or any other scientific, technical, trade or business secret or confidential or proprietary information of the Company or of any third party provided to you during the Term. In the
event anyone not employed or otherwise engaged by the Company seeks information from you in regard to any such Confidential Information or any other secret or confidential work of the Company, or
concerning any fact or circumstance relating thereto, you will promptly notify the chief executive officer of the Company. 



A-4







 

        (b)    Limited Exceptions.    The restrictions in Section 2(a) hereof shall not apply to information that, as
can be established by competent written records: (i) was publicly known at the time of the Company's communication thereof to you; (ii) becomes publicly known through no fault of yours
subsequent to the time of the Company's communication thereof to you; (iii) was in your possession free of any obligation of confidence at the time of the Company's communication thereof to
you; or (iv) is developed by you independently of and without reference to or use of any of the Company's Confidential Information. In the event that you are required by law, regulation or
court order to disclose any of the Company's Confidential Information, you shall (i) first notify the Company of such disclosure requirement and (ii) furnish only that portion of the
Confidential Information that is legally required and will exercise all reasonable efforts to obtain reliable assurances that confidential treatment will be accorded the Confidential Information. 



        (c)    Survival of Acknowledgements and Agreements.    Except as expressly set forth hereunder, your acknowledgements
and agreements set forth in this Section 2 shall survive the termination of your employment with the Company. 




        3.    Ownership of Intellectual Property Ideas.    



        (a)    Property of the Company.    As used in this Agreement, the term "Inventions" shall mean all ideas, discoveries,
creations, manuscripts and properties, innovations, improvements, know-how, inventions, designs, developments, apparatus, techniques, methods, biological processes, cell lines, laboratory
notebooks and formulae, whether patentable, copyrightable or not, including all rights to obtain, register, perfect and enforce any of the foregoing. You hereby agree that any Inventions which you may
conceive, reduce to practice or develop during the Term in connection with the business activities of the Company or otherwise within the Field of Interest, alone or in conjunction with any other
party, whether during or out of regular business hours, and whether at the request or upon the suggestion of the Company, or otherwise (collectively, the "Company Inventions"), shall be the sole and
exclusive property of the Company. You hereby assign to the Company all of your right, title and interest in and to all such Company Inventions and hereby agree that you shall not publish any of the
Company Inventions without the prior written consent of the Company. 


        (b)    Cooperation.    During the Term, you agree that, without further compensation, you will disclose promptly to
the Company in writing, all Company Inventions you conceive, reduce to practice or develop during the Term (or, if based on or related to any Confidential Information of the Company obtained by you
during the Term, within one (1) year after the termination of your employment). You further agree that you will fully cooperate with the Company, its attorneys and agents in the preparation and
filing of all papers and other documents as may be reasonably required to perfect the Company's rights in and to any of such Company Inventions, including, but not limited to, joining in any
proceeding to obtain patents, copyrights, trademarks or other legal rights of the United States and of any and all other countries on such Company Inventions;  provided, that, the Company will bear the expense of such proceedings (including all of your reasonable
expenses). You further agree that any patent or other legal right covering any Company Invention so issued to you, personally, shall be assigned by you to the Company without charge by you. You
further acknowledge that all original works of authorship made by you, whether alone or jointly with others within the scope of your employment and which are protectable by copyright are "works made
for hire" within the meaning of the United States Copyright Act, 17 U.S.C. § 101, as amended, the copyright of which shall be owned solely, completely and exclusively by the
Company. If any Company Invention is considered to be work not included in the categories of work covered by the United States Copyright Act, 17 U.S.C. § 101, as amended, such work
shall be owned solely by, or hereby assigned or transferred completely and exclusively to, the Company. If the Company is unable because of your mental or physical incapacity or for any other reason,
after reasonable effort, to secure your signature on any document or documents needed to obtain or 



A-5







 




enforce
any patent, copyright, trademarks or any other rights covering Inventions or original works of authorship assigned by you to the Company as required above, you hereby irrevocably designate and
appoint the Company and its duly authorized officers and agents as your agent and attorney-in-fact, to act for and in your behalf and stead to execute and file any application
or assignment and to do all other lawfully permitted acts to further the prosecution and issuance to the Company of patents, copyright registrations, trademark registrations or similar protections
covering the Inventions with the same legal force and effect as if executed by you. 




        4.    Provisions Necessary and Reasonable/Breach/Attorneys' Fees.    You agree that (i) the provisions of
Sections 1, 2 and 3 of this Agreement are necessary and reasonable to protect the Company's Confidential Information, Company Inventions, and goodwill and (ii) in the event of any breach
of any
of the covenants set forth herein, the Company would suffer substantial irreparable harm and would not have an adequate remedy at law for such breach. In recognition of the foregoing, you agree that
in the event of a breach or threatened breach of any of these covenants, in addition to such other remedies as the Company may have at law, without posting any bond or security, the Company shall be
entitled to seek and obtain equitable relief, in the form of specific performance, and/or temporary, preliminary or permanent injunctive relief, or any other equitable remedy which then may be
available. The seeking of such injunction or order shall not affect the Company's right to seek and obtain damages or other equitable relief on account of any such actual or threatened breach. In the
event the Company takes any court action with respect to your breach or threatened breach of this Agreement, and prevails in such action, you shall be obligated to reimburse the Company for its
reasonable attorneys' fees and costs incurred in such action. 


        5.    Disclosure to Future Employers.    You agree that you will provide, and that the Company may similarly provide
in its discretion, a copy of the covenants contained in Sections 1, 2 and 3 of this Agreement to any business or enterprise which you may directly, or indirectly, own, manage, operate, finance,
join, control or in which you participate in the ownership, management, operation, financing, or control, or with which you may be connected as an officer, director, employee, partner, principal,
agent, representative, consultant or otherwise. 


        6.    Representations Regarding Prior Work and Legal Obligations.    



        (a)   You
represent that you have no agreement or other legal obligation with any prior employer or any other person or entity that restricts your ability to engage in
employment discussions with, employment with, or to perform any function for, the Company. 


        (b)   You
represent that you have been advised by the Company that at no time should you divulge to or use for the benefit of the Company, any trade secret or confidential or
proprietary information of any previous employer. You acknowledge that you have not divulged or used any such information for the benefit of the Company. 



        (c)   You
acknowledge that the Company is basing important business decisions on these representations, and affirm that all of the statements included herein are true. 




        7.    Records.    Upon termination of your employment relationship with the Company, you shall deliver to the Company
any property of the Company which may be in your possession including products, materials, memoranda, notes, records, reports, or other documents or photocopies of the same. 


        8.    No Conflicting Agreements.    You hereby represent and warrant that you have no commitments or obligations
inconsistent with this Agreement and you hereby agree to indemnify and hold the Company harmless against loss, damage, liability or expense arising from any claim based upon circumstances alleged to
be inconsistent with such representation and warranty. 


A-6







 

        9.    General.    



        (a)    Notices.    All notices, requests, consents and other communications hereunder shall be in writing, shall be
addressed to the receiving party's address set forth below or to such other address as a party may designate by notice hereunder, and shall be either (i) delivered by hand, (ii) made by
telex, telecopy or facsimile transmission with confirmed receipt thereof (and with a copy of such telex, telecopy or facsimile, together with a copy of the confirmation sent to the recipient by
regular U.S. mail on the next business day), (iii) sent by overnight courier, or (iv) sent by registered mail, return receipt requested, postage prepaid. 



			
	If to the Company:	 	Synta Pharmaceuticals Corp.

45 Hartwell Avenue

Lexington, MA 02421

Attn: Chief Executive Officer
	
 If to you:	
 	
To the address set forth on the signature page of this Agreement.






        All
notices, requests, consents and other communications hereunder shall be deemed to have been given either (i) if by hand, at the time of the delivery thereof to the receiving
party at the address of such party set forth above, (ii) if made by telex, telecopy or facsimile transmission, at the time that receipt thereof has been acknowledged by electronic confirmation
or otherwise, (iii) if sent by overnight courier, on the next business day following the day such notice is delivered to the courier service, or (iv) if sent by registered mail, on the
fifth business day following the day such mailing is made. 



        (b)    Entire Agreement.    This Agreement embodies the entire agreement and understanding between the parties hereto
with respect to the subject matter hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant
or agreement of any kind not expressly set forth in this Agreement shall affect, or be used to interpret, change or restrict, the express terms and provisions of this Agreement. 


        (c)    Modifications and Amendments.    The terms and provisions of this Agreement may be modified or amended only by
written agreement executed by the parties hereto. 


        (d)    Waivers and Consents.    The terms and provisions of this Agreement may be waived, or consent for the departure
therefrom granted, only by written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall constitute a waiver or
consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for
which it was given, and shall not constitute a continuing waiver or consent. 


        (e)    Assignment.    The Company may assign its rights and obligations hereunder to any person or entity that
succeeds to all or substantially all of the Company's business or that aspect of the Company's business in which you are principally involved. Your rights and obligations under this Agreement may not
be assigned by you without the prior written consent of the Company. 



        (f)    Benefit.    All statements, representations, warranties, covenants and agreements in this Agreement shall be
binding on the parties hereto and shall inure to the benefit of the respective successors and permitted assigns of each party hereto. Nothing in this Agreement shall be construed to create any
rights or obligations except among the parties hereto, and no person or entity shall be regarded as a third-party beneficiary of this Agreement. 



A-7







 

        (g)    Governing Law.    This Agreement and the rights and obligations of the parties hereunder shall be construed in
accordance with and governed by the laws of the Commonwealth of Massachusetts, without giving effect to the conflict of laws principles thereof. 


        (h)    Jurisdiction.    Any legal action or proceeding with respect to this Agreement may be brought in the courts of
the Commonwealth of Massachusetts or of the United States of America. By execution and delivery of this Agreement, each of the parties hereto accepts for itself and in respect of its property,
generally and unconditionally, the jurisdiction of the aforesaid courts. 


        (i)    Severability.    The parties intend this Agreement to be enforced as written. However, (i) if any
portion or provision of this Agreement shall to any extent be declared illegal or unenforceable by a duly authorized court having jurisdiction, then the remainder of this Agreement, or the application
of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement
shall be valid and enforceable to the fullest extent permitted by law and (ii) if any provision, or part thereof, is held to be unenforceable because of the duration of such provision or the
geographic area covered thereby, the Company and you agree that the court making such determination shall have the power to reduce the duration and/or geographic area of such provision, and/or to
delete specific words and phrases ("blue-penciling"), and in its reduced or blue-penciled form such provision shall then be enforceable and shall be enforced. 


        (j)    Headings and Captions.    The headings and captions of the various subdivisions of this Agreement are for
convenience of reference only and shall in no way modify, or affect the meaning or construction of any of the terms or provisions hereof. 



        (k)    No Waiver of Rights, Powers and Remedies.    No failure or delay by a party hereto in exercising any right,
power or remedy under this Agreement, and no course of dealing between the parties hereto, shall operate as a waiver of any such right, power or remedy of the party. No single or partial exercise of
any right, power or remedy under this Agreement by a party hereto, nor any abandonment or discontinuance of steps to enforce any such right, power or remedy, shall preclude such party from any other
or further exercise thereof or the exercise of any other right, power or remedy hereunder. The election of any remedy by a party hereto shall not constitute a waiver of the right of such party to
pursue other available remedies. No notice to or demand on a party not expressly required under this Agreement shall entitle the party receiving such notice or demand to any other or further notice or
demand in similar or other circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other or further action in any circumstances without such notice or
demand. 


        (l)    Counterparts.    This Agreement may be executed in one or more counterparts, and by different parties hereto on
separate counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 



A-8







 

        If
the foregoing accurately sets forth our agreement, please so indicate by signing and returning to us the enclosed copy of this letter. 



					
	 	 	Very truly yours,
	

 	
 	
SYNTA PHARMACEUTICALS CORP.
	

 	
 	
By:	
 	
/s/ SAFI BAHCALL






  Safi Bahcall, Ph.D.

Director, President and Chief Executive Officer





					
	Agreed to and accepted:
	Name:	 	/s/ MICHAEL P. BAILEY






  Michael P. Bailey	 	 
	Address:	 	[ADDRESS]	 	 
	Date:	 	7/9/08	 	 




A-9











QuickLinks



Exhibit 10.2